Delivery Order SPE2DR25D1100-SPE2DR26FCM3D
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count) on May 2, 2025, with an ultimate completion date of May 23, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major healthcare solutions provider and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. The award was made on July 30, 2025, with an ultimate completion date of August 20, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the delivery from its corporate office location. This delivery order represents a specific...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ingrezza 60 mg capsules (30-count packages) valued at $4,049.61. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,676.11 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count packages) under a firm fixed-price contract. The delivery order, awarded on October 31, 2025, with an ultimate completion date of November 24, 2025, carries no set-aside designation and represents a competitively awarded transaction. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $8,055.40 on August 21, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $7,748.14. This firm fixed-price delivery order, which will be completed by November 24, 2025, carries no set-aside designation and represents a competitively awarded transaction. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) with a ceiling value of $11,028.36. This firm fixed-price delivery order, which is neither set-aside nor restricted, represents a competitively awarded procurement supporting federal medical supply needs. The work is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate office...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCM3DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,267.66 to AmerisourceBergen Drug Corp for the supply of Ingrezza 60 mg capsules (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price, non-set-aside delivery order represents a pediatric pharmaceutical supply requirement fulfilled through the vendor's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The contract serves multiple government healthcare entities, including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 11/3/25 |